• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清外泌体微小RNA-21在儿童肝母细胞瘤中的诊断和预后价值:一项基于中国人群的研究

Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study.

作者信息

Liu Wanbo, Chen Sheng, Liu Bing

机构信息

Department of Medical Affairs, The General Hospital of the PLA Rocket Force, Beijing, China.

Department of General Surgery, The General Hospital of the PLA Rocket Force, Beijing, China.

出版信息

Pediatr Surg Int. 2016 Nov;32(11):1059-1065. doi: 10.1007/s00383-016-3960-8. Epub 2016 Sep 6.

DOI:10.1007/s00383-016-3960-8
PMID:27601233
Abstract

BACKGROUND

Hepatoblastoma (HB) is the most common primary malignant tumor of the liver in young children. The aim of this study is to identify the diagnostic and prognostic values of serum exosomal miR-21 in Chinese patients with HB.

METHODS

We retrospectively reviewed 32 children with HB. The expressions of miR-21 were detected by real-time PCR. The comparison of diagnostic performance of plasmatic, exosomal miR-21 and AFP levels was measured using the Area Under ROC Curve.

RESULTS

For patients in HB group, miR-21 concentration was significantly higher in the exosomes compared with the exosome-depleted supernatants and whole plasma. Expression of miR-21 was significantly higher in patients with HB compared with control group in both plasma and exosomes. With respect to the diagnosis of patients with HB, exosomal miR-21 was significantly more accurate compared with the Alpha-fetoprotein levels. Moreover, exosomal miR-21 was an independent predictor of Even-free survival for patients with HB.

CONCLUSIONS

In this study, we found that expression of miR-21 was significantly higher in patients with HB compared with control group in both plasma and exosomes, and we confirmed that exosomal miR-21 could be defined as a diagnostic and prognostic biomarker for patients with HB.

摘要

背景

肝母细胞瘤(HB)是幼儿最常见的原发性肝脏恶性肿瘤。本研究旨在确定血清外泌体miR-21在中国HB患者中的诊断和预后价值。

方法

我们回顾性分析了32例HB患儿。采用实时PCR检测miR-21的表达。使用ROC曲线下面积测量血浆、外泌体miR-21和甲胎蛋白水平的诊断性能比较。

结果

对于HB组患者,与去除外泌体的上清液和全血浆相比,外泌体中miR-21浓度显著更高。在血浆和外泌体中,HB患者的miR-21表达均显著高于对照组。关于HB患者的诊断,外泌体miR-21比甲胎蛋白水平显著更准确。此外,外泌体miR-21是HB患者无事件生存期的独立预测指标。

结论

在本研究中,我们发现血浆和外泌体中HB患者的miR-21表达均显著高于对照组,并且我们证实外泌体miR-21可被定义为HB患者的诊断和预后生物标志物。

相似文献

1
Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study.血清外泌体微小RNA-21在儿童肝母细胞瘤中的诊断和预后价值:一项基于中国人群的研究
Pediatr Surg Int. 2016 Nov;32(11):1059-1065. doi: 10.1007/s00383-016-3960-8. Epub 2016 Sep 6.
2
Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.外泌体miR-34s组合作为肝母细胞瘤患者潜在的新型诊断和预后生物标志物。
J Pediatr Surg. 2017 Apr;52(4):618-624. doi: 10.1016/j.jpedsurg.2016.09.070. Epub 2016 Oct 14.
3
Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.外泌体 microRNA-224 在肝癌发展中的作用及其诊断和预后价值。
World J Gastroenterol. 2019 Apr 21;25(15):1890-1898. doi: 10.3748/wjg.v25.i15.1890.
4
Glypican 3 as a Serum Marker for Hepatoblastoma.磷脂酰聚糖 3 作为肝母细胞瘤的血清标志物。
Sci Rep. 2017 Apr 5;7:45932. doi: 10.1038/srep45932.
5
Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.血清外泌体微小RNA作为肝细胞癌的新型生物标志物
Exp Mol Med. 2015 Sep 18;47(9):e184. doi: 10.1038/emm.2015.68.
6
Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.血清外泌体 miR-301a 作为人类神经胶质瘤潜在的诊断和预后生物标志物。
Cell Oncol (Dordr). 2018 Feb;41(1):25-33. doi: 10.1007/s13402-017-0355-3. Epub 2017 Oct 26.
7
Combined low miR-34s are associated with unfavorable prognosis in children with hepatoblastoma: A Chinese population-based study.低 miR - 34s 联合表达与儿童肝母细胞瘤预后不良相关:一项基于中国人群的研究。
J Pediatr Surg. 2016 Aug;51(8):1355-61. doi: 10.1016/j.jpedsurg.2016.02.091. Epub 2016 Mar 14.
8
Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma.血清外泌体 microRNAs 作为肝细胞癌诊断和预后生物标志物的开发和验证。
J Cell Biochem. 2019 Jan;120(1):135-142. doi: 10.1002/jcb.27165. Epub 2018 Sep 20.
9
Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.循环外泌体微小RNA-21作为结直肠癌各肿瘤分期的生物标志物
Oncology. 2017;92(6):360-370. doi: 10.1159/000463387. Epub 2017 Apr 5.
10
Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.循环外泌体miR-373、miR-200a、miR-200b和miR-200c在上皮性卵巢癌患者中的诊断和预后相关性
Oncotarget. 2016 Mar 29;7(13):16923-35. doi: 10.18632/oncotarget.7850.

引用本文的文献

1
Identification of MAD2L1 as a novel biomarker for hepatoblastoma through bioinformatics and machine learning approaches.通过生物信息学和机器学习方法鉴定MAD2L1作为肝母细胞瘤的新型生物标志物。
Front Oncol. 2025 Mar 31;15:1524714. doi: 10.3389/fonc.2025.1524714. eCollection 2025.
2
Role of exosomes in diagnosis, prognostication, and treatment of pediatric solid tumors.外泌体在儿童实体瘤诊断、预后评估及治疗中的作用。
Mol Ther Oncol. 2024 Dec 30;33(1):200930. doi: 10.1016/j.omton.2024.200930. eCollection 2025 Mar 20.
3
Unlocking the Secrets of Extracellular Vesicles: Orchestrating Tumor Microenvironment Dynamics in Metastasis, Drug Resistance, and Immune Evasion.

本文引用的文献

1
MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer.微小RNA-21促进结直肠癌中磷酸酶基因及蛋白激酶B/磷脂酰肌醇3-激酶的表达。
World J Gastroenterol. 2016 Jun 28;22(24):5532-9. doi: 10.3748/wjg.v22.i24.5532.
2
Multi-platform microRNA profiling of hepatoblastoma patients using formalin fixed paraffin embedded archival samples.使用福尔马林固定石蜡包埋存档样本对肝母细胞瘤患者进行多平台微小RNA分析。
Gigascience. 2015 Nov 25;4:54. doi: 10.1186/s13742-015-0099-9. eCollection 2015.
3
Exosomes in cancer: small particle, big player.
揭开细胞外囊泡的秘密:调控肿瘤微环境在转移、耐药和免疫逃逸中的动态变化
J Cancer. 2024 Oct 14;15(19):6383-6415. doi: 10.7150/jca.98426. eCollection 2024.
4
A comprehensive overview of liquid biopsy applications in pediatric solid tumors.液体活检在儿科实体瘤中的应用综述
NPJ Precis Oncol. 2024 Aug 3;8(1):172. doi: 10.1038/s41698-024-00657-z.
5
Extracellular Vesicles for Childhood Cancer Liquid Biopsy.用于儿童癌症液体活检的细胞外囊泡
Cancers (Basel). 2024 Apr 26;16(9):1681. doi: 10.3390/cancers16091681.
6
Ferroptosis regulator NOS2 is closely associated with the prognosis and cell malignant behaviors of hepatoblastoma: a bioinformatic and study.铁死亡调节因子NOS2与肝母细胞瘤的预后及细胞恶性行为密切相关:一项生物信息学研究
Front Oncol. 2023 Sep 19;13:1228199. doi: 10.3389/fonc.2023.1228199. eCollection 2023.
7
Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules.癌症中的外泌体微小RNA:免疫检查点分子的潜在生物标志物和免疫治疗靶点。
Front Genet. 2023 Feb 17;14:1052731. doi: 10.3389/fgene.2023.1052731. eCollection 2023.
8
The Role of miRNAs, circRNAs and Their Interactions in Development and Progression of Hepatocellular Carcinoma: An Approach.miRNAs、circRNAs 及其相互作用在肝细胞癌发生发展中的作用:一种研究方法。
Genes (Basel). 2022 Dec 21;14(1):13. doi: 10.3390/genes14010013.
9
Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis.循环外泌体微小RNA作为胃肠道癌症潜在的预后生物标志物:一项系统评价和荟萃分析
Cancer Cell Int. 2023 Jan 20;23(1):10. doi: 10.1186/s12935-023-02851-8.
10
Isolation and characterization of extracellular vesicles for clinical applications in cancer - time for standardization?用于癌症临床应用的细胞外囊泡的分离与表征——是时候标准化了吗?
Nanoscale Adv. 2021 Feb 16;3(7):1830-1852. doi: 10.1039/d0na00676a. eCollection 2021 Apr 6.
癌症中的外泌体:小颗粒,大作用。
J Hematol Oncol. 2015 Jul 10;8:83. doi: 10.1186/s13045-015-0181-x.
4
MiRNA-based therapeutic intervention of cancer.基于微小RNA的癌症治疗干预
J Hematol Oncol. 2015 Jun 11;8:68. doi: 10.1186/s13045-015-0162-0.
5
Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer.循环中的miR-199a-3p作为结直肠癌的一种新型血清生物标志物。
Oncol Rep. 2014 Dec;32(6):2354-8. doi: 10.3892/or.2014.3515. Epub 2014 Sep 24.
6
miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer.微小RNA-133a在胰腺癌中发挥肿瘤抑制作用,并直接靶向丝状肌动蛋白1。
Oncol Res. 2013;21(6):353-63. doi: 10.3727/096504014X14024160459122.
7
Predictors of survival after resection of children with hepatoblastoma: A single Asian center experience.肝母细胞瘤患儿切除术后生存的预测因素:一个亚洲单一中心的经验
Eur J Surg Oncol. 2014 Nov;40(11):1533-9. doi: 10.1016/j.ejso.2014.07.033. Epub 2014 Jul 24.
8
microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics.肿瘤微环境中的 microRNAs:为更好的诊断解开谜团。
Expert Rev Mol Diagn. 2014 Jun;14(5):565-74. doi: 10.1586/14737159.2014.922879.
9
MicroRNA expression might predict prognosis of epithelial hepatoblastoma.微小 RNA 的表达可能预测上皮性肝母细胞瘤的预后。
Virchows Arch. 2014 Apr;464(4):419-27. doi: 10.1007/s00428-014-1549-y. Epub 2014 Feb 26.
10
Tumor cell-derived exosomes: a message in a bottle.肿瘤细胞衍生的外泌体:瓶中信使
Biochim Biophys Acta. 2012 Aug;1826(1):103-11. doi: 10.1016/j.bbcan.2012.03.006. Epub 2012 Apr 1.